Kevin Kalish: Circulating the Cerebrospinal Fluid for Drug Delivery with Enclear Therapies
Update: 2023-02-08
Description
Kevin Kalish is the COO of Enclear Therapies, a biotechnology company that has developed a novel platform for delivering therapeutics to hard-to-reach areas of the central nervous system by circulating the Cerebrospinal Fluid. Enclear's innovative technology holds promise as a means to treat a variety of neuro-oncological and neurodegenerative diseases. In this conversation with Kevin, we discuss the technology, its initial indications, its promises, and the challenges that must be overcome to get there.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
